Search results
Results from the WOW.Com Content Network
Mount Sinai Journal of Medicine: Medicine: John Wiley & Sons: English: 1934–2012 Movement Disorders: Neurology: Wiley-Liss: English: 1986–present Myanmar Medical Journal: Medicine: Myanmar Medical Association: English: 1953–present Nano Biomedicine and Engineering: Medicine: Open-Access House of Science and Technology: English: 2009–present
HIV Medicine is a bimonthly peer-reviewed medical journal covering HIV/AIDS research. It was established in 1999 and is published by Wiley-Blackwell on behalf of the British HIV Association, of which it is the official journal. It is also the official journal of the European AIDS Clinical Society and the Australasian Society for HIV Medicine. [1]
Antiretroviral drugs are used to manage HIV/AIDS. Multiple antiretroviral drugs are often combined into a single pill in order to reduce pill burden. Some of these combinations are complete single-tablet regimens; the others must be combined with additional pills to make a treatment regimen.
Journal of Medicine in Scientific Research; Journal of Medicine in the Tropics; Journal of Mental Health and Human Behaviour; Journal of Microscopy and Ultrastructure; Journal of Mid-Life Health; Journal of Minimal Access Surgery; Journal of Musculoskeletal Surgery and Research; Journal of National Accreditation Board for Hospitals & Healthcare ...
Journals devoted to publishing research pertaining to HIV/AIDS. Pages in category "HIV/AIDS journals" The following 16 pages are in this category, out of 16 total.
International Journal of Clinical Transfusion Medicine; International Journal of General Medicine; International Journal of High Throughput Screening † International Journal of Interferon, Cytokine and Mediator Research † International Journal of Nanomedicine; International Journal of Nephrology and Renovascular Disease
It works by inhibiting the enzyme reverse transcriptase that HIV uses to make DNA and therefore decreases replication of the virus. [6] Zidovudine was first described in 1964. [7] It was resynthesized from a public-domain formula by Burroughs Wellcome. [8] It was approved in the United States in 1987 and was the first treatment for HIV.
SARS-CoV-2 and HIV-1 have similarities—notably both are RNA viruses—but there are important differences. As a retrovirus, HIV-1 can insert a copy of its RNA genome into the host's DNA, making total eradication more difficult. [156] The virus is also highly mutable making it a challenge for the adaptive immune system to develop a response.